MarketWatch
Analyze & Strategize
Top News
Rakesh Jhunjhunwala Portfolio: Analysts Predict Up To 24% Returns on Tata Stock; Do you Own? – News18
Hotels Company (IHCL), included in ace investor Rakesh Jhunjhunwaala’s portfolio, has outperformed the Nifty50 benchmark this year so far. Should you Buy, Sell or Hold the hospitality sector stock? Read More
reported by Aparna Deb at News18
ONGC slumps 9%, BPCL 5% on reports of windfall tax plans – Moneycontrol
Oil stocks moved lower amid reports that the government could seek to capitalise on global windfalls boosting oil and gas revenues to offset inflation and burgeoning subsidies Read More
reported by Jocelyn Fernandes at Moneycontrol
Ola S1 owner explains how he managed to get 200 Kms on a single charge – CarToq.com
Some people have been able to achieve around 200 km of riding range on a single charge on their S1 Pro electric scooter. This is quite impressive considering Ola Electric claims a true riding range of 135 km. Many people wanted to know how did the rider was a? Read More
reported by Paarth Khatri at CarToq.com
Terminated fund manager sends legal notice to Axis Mutual Fund – Economic Times
Viresh Joshi, fund manager and chief dealer at Axis Mutual Fund, has sent a legal notice to the fund house against his ?unlawful termination. Read More
reported by Shivani Bazaz at The Times of India
Meet the most robust App for smartest Traders
Analyze.
Strategize.
Stay Ahead,
Always.
Downloads
From the blogs
Logistics platform MatchLog raises $3mn from Blue Ashva Capital, Rainmatter Climate and Capital Moneycontrol
MatchLog plans to grow the multi-modal share in addition to road transport and expand its footprint to more ports in India and abroad Read More reported by at...
Explained: Two new oral drugs and the treatment of Covid The Indian Express
While several drugs have been part of treatment protocols through the pandemic, no orally administered drug had got regulatory clearance in any country until molnupiravir. Read More reported by Kaunain Sheriff M at The Indian...
Explained: Two new oral drugs and the treatment of Covid The Indian Express
While several drugs have been part of treatment protocols through the pandemic, no orally administered drug had got regulatory clearance in any country until molnupiravir. Read More reported by Kaunain Sheriff M at The Indian...